Bichl
Germany
43
2023-03-02
The entities that hold a legal rights for patent applications filed by inventor Block Dirk:
Dirk Block from Bichl, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#2 | 2022-12-29IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#3 | 2022-06-30MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#4 | 2022-02-03BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE
#5 | 2021-06-03Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
#6 | 2020-11-26BIOMARKERS FOR RISK PREDICTION OF MORTALITY
#7 | 2020-08-27Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#8 | 2020-02-27Use of IGFBP-7 in the assessment of heart failure
#9 | 2019-11-21Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
#10 | 2019-09-12SOLUBLE ST2 FOR THE IDENTIFICATION OF PROGRESSORS TO LVH IN THE GENERAL POPULATION
#11 | 2019-09-12IGFBP7 for diagnosing diastolic dysfunction
#12 | 2019-05-23Marker for statin treatment stratification in heart failure
#13 | 2018-12-20IGFBP-7 as a marker of preeclampsia
#14 | 2018-11-01NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
#15 | 2018-08-16IGFBP7 for prediction of risk of AKI when measured prior to surgery
#16 | 2018-07-12Assessing whether a subject shall be subjected to imaging based diagnostic
#17 | 2017-08-10Biomarkers for risk prediction of mortality
#18 | 2017-03-16TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#19 | 2017-01-19Use of IGFBP-7 in the assessment of heart failure
#20 | 2017-01-12IGFBP7 for diagnosing diastolic dysfunction
#21 | 2016-11-17Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#22 | 2016-07-19Method for bisulfite treatment
#23 | 2016-06-16Marker for statin treatment stratification in heart failure
#24 | 2016-05-26USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE
#25 | 2016-03-10Method for bisulfite treatment
#26 | 2015-10-15USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#27 | 2015-09-24BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE
#28 | 2015-08-20TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#29 | 2015-08-20NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
#30 | 2015-07-02IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#31 | 2015-03-19Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
#32 | 2014-07-10USE OF SFRP-3 IN THE ASSESSMENT OF HEART FAILURE
#33 | 2014-03-06USE OF BIOMARKERS IN THE ASSESSMENT OF THE EARLY TRANSITION FROM ARTERIAL HYPERTENSION TO HEART FAILURE
#34 | 2012-06-21Use of mimecan in the assessment of heart failure
#35 | 2012-06-21Method and device for purifying nucleic acids
#36 | 2012-01-12ENDOSTATIN AS A MARKER OF HEART FAILURE
#37 | 2011-07-07USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE
#38 | 2011-06-09Method and device for purifying nucleic acids
#39 | 2011-02-03Use of SFRP-3 in the assessment of heart failure
#40 | 2010-11-11Use of SLIM-1 in the assessment of heart failure
#41 | 2010-11-11USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#42 | 2006-03-16Method for bisulfite treatment
#43 | 2005-09-22Method and device for purifying nucleic acids
676870 ⎘